Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Benzenoids
  6. Naphthalenes
  7. UVI 3003, Tocris Bioscience™

UVI 3003, Tocris Bioscience™

Catalog No. 330310
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Description

RXR antagonist

RXR antagonist; displays high RXR binding affinity. Does not affect the corepressor interaction capacity of the RARα subunit within the context of the RAR-RXR heterodimer.

Chemical Identifiers

CAS 847239-17-2
Molecular Formula C28H36O4
Molecular Weight (g/mol) 436.592
InChI Key APJSHECCIRQQDV-ZRDIBKRKSA-N
Synonym compound 10e pmid: 19408900, d09ien, 3-4-hydroxy-3-5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-pentyloxy-2-naphthalenyl phenyl-2-propenoicacid, e-3-4-hydroxy-3-1,1,4,4-tetramethyl-7-pentoxy-tetralin-6-yl phenyl prop-2-enoic acid, 2e-3-4-hydroxy-3-5,5,8,8-tetramethyl-3-pentyloxy-5,6,7,8-tetrahydronaphthalen-2-yl phenyl prop-2-enoic acid, 3-4-hydroxy-3-5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-pentyloxy-2-naphthalenyl phenyl-2-propenoic acid
PubChem CID 44566108
IUPAC Name (E)-3-[4-hydroxy-3-(5,5,8,8-tetramethyl-3-pentoxy-6,7-dihydronaphthalen-2-yl)phenyl]prop-2-enoic acid
SMILES CCCCCOC1=CC2=C(C=C1C3=C(C=CC(=C3)C=CC(=O)O)O)C(CCC2(C)C)(C)C

Specifications

Quantity 10 mg
Formula Weight 436.58
Percent Purity >98%
Chemical Name or Material UVI 3003

Safety and Handling

Recommended Storage Store at -20°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.